GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (XTER:TLIK) » Definitions » EV-to-FCF

Arzneiwerk AG VIDA (XTER:TLIK) EV-to-FCF : 684.22 (As of Apr. 08, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Arzneiwerk AG VIDA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Arzneiwerk AG VIDA's Enterprise Value is €12.32 Mil. Arzneiwerk AG VIDA's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €0.02 Mil. Therefore, Arzneiwerk AG VIDA's EV-to-FCF for today is 684.22.

The historical rank and industry rank for Arzneiwerk AG VIDA's EV-to-FCF or its related term are showing as below:

XTER:TLIK' s EV-to-FCF Range Over the Past 10 Years
Min: -131.58   Med: -3.22   Max: 1173.4
Current: 707.06

During the past 13 years, the highest EV-to-FCF of Arzneiwerk AG VIDA was 1173.40. The lowest was -131.58. And the median was -3.22.

XTER:TLIK's EV-to-FCF is ranked worse than
97.22% of 72 companies
in the Medical Distribution industry
Industry Median: 12.38 vs XTER:TLIK: 707.06

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-08), Arzneiwerk AG VIDA's stock price is €0.30. Arzneiwerk AG VIDA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.195. Therefore, Arzneiwerk AG VIDA's PE Ratio (TTM) for today is At Loss.


Arzneiwerk AG VIDA EV-to-FCF Historical Data

The historical data trend for Arzneiwerk AG VIDA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arzneiwerk AG VIDA EV-to-FCF Chart

Arzneiwerk AG VIDA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.95 -4.63 -130.63 - -

Arzneiwerk AG VIDA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.82 - 14.74 8.96 881.23

Competitive Comparison of Arzneiwerk AG VIDA's EV-to-FCF

For the Medical Distribution subindustry, Arzneiwerk AG VIDA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arzneiwerk AG VIDA's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Arzneiwerk AG VIDA's EV-to-FCF falls into.


;
;

Arzneiwerk AG VIDA EV-to-FCF Calculation

Arzneiwerk AG VIDA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12.316/0.018
=684.22

Arzneiwerk AG VIDA's current Enterprise Value is €12.32 Mil.
Arzneiwerk AG VIDA's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arzneiwerk AG VIDA  (XTER:TLIK) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Arzneiwerk AG VIDA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.30/-0.195
=At Loss

Arzneiwerk AG VIDA's share price for today is €0.30.
Arzneiwerk AG VIDA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.195.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Arzneiwerk AG VIDA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Arzneiwerk AG VIDA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Arzneiwerk AG VIDA Business Description

Traded in Other Exchanges
Address
Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.

Arzneiwerk AG VIDA Headlines

No Headlines